$10.910
-0.029 (-0.27%)At close
ARDT News
ARDT Events
Ardent Health Expands Medical Services with UT Health East Texas Partnership
Ardent Health marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the new UT Tyler School of Medicine Building in Tyler - the first time patient services and physician training share a single hub in the region. The building now houses UT Health East Texas women's health, pulmonary, orthopedic, imaging and surgical care alongside the region's first medical school. The expansion builds on the joint venture Ardent formed with The University of Texas System in 2018 to expand access to care and grow the local physician workforce in a region facing persistent health challenges. Northeast Texas, a 35-county area of roughly 1.6M people, would rank among the least healthy states in the country if measured on its own, according to research led by UT Tyler.
Ardent Health Reports Q2 Revenue of $1.62B
Reports Q2 revenue $1.62B, consensus $1.59B. "As I transition to the CEO role, I'm looking forward to building on the momentum of key initiatives launched during my COO tenure as well as Ardent's strong foundation in attractive, growing markets," said Dave Caspers, President and Chief Executive Officer of Ardent Health. "I see clear opportunities to further improve performance and unlock the full potential of the platform. Our growth strategy remains unchanged, but sharpening operational execution is my highest priority. We are focused on the levers we can control - staffing, contracting, capital allocation, standardization and accountability - while continuing to deliver high-quality care to the patients and communities we serve."
Company Confirms FY26 Revenue Outlook of $6.4B to $6.7B
Backs FY26 revenue view $6.4B-$6.7B, consensus $6.44B.
Morgan Stanley Maintains Equal Weight Rating on Ardent Health with $12 Price Target
Morgan Stanley notes after Ardent Health announced the appointment of COO Dave Caspers as President and CEO, effective immediately, that the CFO and investor relations team commented that the CEO transition was driven by the board in response to a more challenging macro backdrop for health systems. The firm, which says that Ardent's commentary of softer volumes in Q2 "adds to a growing list of investor concerns in the hospital group," has an Equal Weight rating and $12 price target on the shares.
Ardent Health Appoints Dave Caspers as CEO
Ardent Health announced that Dave Caspers has been appointed President and Chief Executive Officer, effective immediately. Mr. Caspers, who previously served as Chief Operating Officer, succeeds Marty Bonick, who has stepped down to pursue other opportunities. In addition, Mr. Caspers has been appointed to the Company's Board of Directors.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.